Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus.
Open Access
- 1 August 1982
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 41 (4), 347-351
- https://doi.org/10.1136/ard.41.4.347
Abstract
Twenty patients with active systemic lupus erythematosus (SLE) were treated with methyl prednisolone pulse therapy (MPPT) and followed up for up to 24 weeks (mean 18 weeks). Beneficial effects of MPPT were observed principally on arthralgia, pleuritic pain, vasculitic skin rash, pyrexia, and lymphadenopathy. The serological tests showing the most improvement were ds DNA binding and the serum C3 level. MPPT was found to be both safe and easy to administer. It may be of value in treating patients with SLE whose disease is not controlled by moderate doses of corticosteroids and may also enable the dose of maintenance corticosteroids to be reduced appreciably.This publication has 18 references indexed in Scilit:
- Plasma exchange in systemic lupus erythematosus.Annals Of The Rheumatic Diseases, 1981
- Methylprednisolone pulse therapy for nonrenal lupus erythematosus.Annals Of The Rheumatic Diseases, 1980
- Intravenous methylprednisolone in minimal change nephrotic syndrome.BMJ, 1980
- High-dose corticosteroids: their use in treating idiopathic rapidly progressive glomerulonephritisArchives of Internal Medicine, 1979
- The treatment of lupus nephritis by methyl prednisolone pulse therapyPublished by Oxford University Press (OUP) ,1978
- Methylprednisolone pulse therapy in the treatment of polyarteritis nodosaPublished by Oxford University Press (OUP) ,1977
- SERUM IMMUNE COMPLEXES AND DISEASE ACTIVITY IN LUPUS NEPHRITISThe Lancet, 1977
- BENEFICIAL EFFECTS OF METHYLPREDNISOLONE "PULSE" THERAPY IN DIFFUSE PROLIFERATIVE LUPUS NEPHRITISThe Lancet, 1976
- ARTHRALGIA AFTER HIGH-DOSE STEROIDSThe Lancet, 1975
- ACUTE ARTHRALGIA AFTER HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONEThe Lancet, 1974